focus -WSS

focus

author：focus 2025-09-29 21:28:48 - browse：45927

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Free speech concerns arise in wake of journal editor Eisen's firing

focus

Wikipedia

WSS

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

What it's like to live with paralysis for one psychologist

Will the FTC rein in IQVIA's health data empire?

White House calls on federal agencies to crack down on AI abuses

Medicare solvency divides Republicans at the presidential debate

STAT Executive Editor Rick Berke on STAT's 8th birthday

leisure time

focus

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Bright Health sells Medicare Advantage business to Molina

The new shift in health care is toward less care

Affirmative action in medical school literally saved lives

More doctors should go into startup world

Duchenne breakthrough therapy leaves behind pioneering families

MoonLake credibility takes another hit with mid

Alkermes shareholders re

How doctors’ personal politics affect patients

Wikipedia

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Device maker Teleflex to acquire urology company for $600M

A clever new way to fix Medicaid and graduate medical education

More doctors should go into startup world

The new shift in health care is toward less care

Biden warns of ‘dark winter’ during final presidental debate

focus

Wikipedia

Wikipedia

focus